CHA₂DS₂-VASc score modestly predicts ischemic stroke, thromboembolic events, and death in patients with heart failure without atrial fibrillation

Keyphrases

• CHA2DS2-VASc Score 100%
• Ischemic Stroke 100%
• Atrial Fibrillation 100%
• Patients with Heart Failure 100%
• Heart Disease Diagnosis 19%
• Hospital Diagnosis 14%
• C-statistic 9%
• Prediction Accuracy 9%
• Thromboembolism 9%
• Chronic Obstructive Pulmonary Disease 9%
• Absolute Risk 9%
• Incident Heart Failure 9%
• Prospective Cohort Study 4%
• Hypertension 4%
• Adverse Outcomes 4%
• Myocardial Infarction 4%
• All-cause Mortality 4%
• Anticoagulant Therapy 4%
• Congestive Heart Failure 4%
• Systemic Embolism 4%
• Pulmonary Embolism 4%
• ICD-10 4%
• Risk Stratification 4%
• Negative Predictive Value 4%
• Time-to-event Analysis 4%
• Type 1 Diabetes Mellitus (T1DM) 4%
• Sensitivity Analysis 4%
• Vitamin K Antagonists 4%
• Vascular Disease 4%
• Female Sex 4%
• Primary Outcome Measure 4%
• Cut-off Score 4%
• Denmark 4%
• Primary Diagnosis 4%
• Cerebrovascular Accident 4%
• Heart Failure Patients 4%
• Cancer Diagnosis 4%
• Sample Splitting 4%
• Transient Ischemic Attack 4%
• Prescription Data 4%
• Risk of Ischemic Stroke 4%
• Hospital Admission 4%
• Clinical Utility 4%
• CHA2DS2-VASc 4%
• Registry System 4%
• Sample Analysis 4%
• Atrial Flutter 4%
• Vital Statistics 4%
• Demographic Statistics 4%
• Danish Registry 4%
• National Patient Registry 4%
• Prescription Registry 4%
• Civil Registry 4%

Medicine and Dentistry

• CHA2DS2-VASc Score 100%
• Atrial Fibrillation 100%
• Congestive Heart Failure 100%
• Thromboembolism 100%
• Brain Ischemia 100%
• Chronic Obstructive Pulmonary Disease 9%
• Malignant Neoplasm 4%
• Adverse Outcome 4%
• Anticoagulant Therapy 4%
• Myocardial Infarction 4%
• Vascular Disease 4%
• Patient Registry 4%
• Prospective Cohort Study 4%
• Diabetes Mellitus 4%
• Pulmonary Embolism 4%
• Vitamin K Antagonist 4%
• Transient Ischemic Attack 4%
• Cause of Death 4%
• ICD-10 4%
• Atrial Flutter 4%
• Vital Statistic 4%

Pharmacology, Toxicology and Pharmaceutical Science

• Atrial Fibrillation 100%
• Congestive Heart Failure 100%
• Brain Ischemia 100%
• Thromboembolism 100%
• Chronic Obstructive Lung Disease 9%
• Malignant Neoplasm 4%
• Adverse Outcome 4%
• Heart Infarction 4%
• Vascular Disease 4%
• Prospective Cohort Study 4%
• Diabetes Mellitus 4%
• Anticoagulation Therapy 4%
• Antivitamin K 4%
• Lung Embolism 4%
• Cause of Death 4%
• Transient Ischemic Attack 4%
• ICD-10 4%
• Heart Atrium Flutter 4%
• Patient Registry 4%
• Vital Statistic 4%